Lv2
150 积分 2024-01-21 加入
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
3小时前
已完结
Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo
13天前
已完结
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024）
1个月前
已完结
Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023
6个月前
已完结
Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study
10个月前
已完结
5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study
1年前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
1年前
已完结
Small extracellular vesicles delivering lncRNA WAC-AS1 aggravate renal allograft ischemia‒reperfusion injury by inducing ferroptosis propagation
1年前
已完结
A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review
1年前
已完结
皖公网安备34019202002308
